TF and cervical carcinoma: We evaluated ELK1, a low peak group TF, across three biologically diverse cell lines using cross-validation: HeLa-S3 (cervical carcinoma, 6091 peaks), K562 (chronic myelogenous leukemia, 3793 peaks), and GM12878 (B-lymphoblastoid, 7245 peaks).